• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2020 May 26;7(8):ofaa181.
doi: 10.1093/ofid/ofaa181. eCollection 2020 Aug.
Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine


Jia-Qian Cao[SUP] 1 [/SUP], Peng-Fei Jin[SUP] 2 [/SUP], Jing-Xin Li[SUP] 2 [/SUP], Zhao-Zhun Zeng[SUP] 3 [/SUP], Li Zhang[SUP] 2 [/SUP], Fan-Yue Meng[SUP] 2 [/SUP], Kai Chu[SUP] 2 [/SUP], Yuan-Yuan Wang[SUP] 1 [/SUP], Feng-Cai Zhu[SUP] 1 4 5 [/SUP]



Affiliations

Abstract

Background: In this study, we investigated the effects of prior influenza exposure on vaccine-elicited humor immune responses to circulating influenza variants.
Method: We randomly selected 360 participants in previous clinical trials stratified by age. Blood samples were collected and tested by hemagglutination-inhibition tests during the 2015-2016 influenza seasons in China. The antigenic map was plotted and antigenic distance was calculated.
Results: Subjects with H1-priming had higher cross-reactive antibodies titers against A/JiangsuTinghu/11019/2015(H3N2) compared with subjects with B-priming did (P [SUB]adjusted[/SUB] = .038). Subjects with H1-priming also had higher cross-reactive antibodies titers against A/Jiangsu Qinhuai/11059/2015(H3N2) than subjects with both H1 and B priming (P [SUB]adjusted[/SUB] = .036). Nevertheless, subjects with no H1 and B-priming had higher cross-reactive antibodies titers against A/Jiangsu Qinhuai/11059/2015(H3N2) than subjects with both H1 and B priming (P [SUB]adjusted[/SUB] = .012). Antigenic distance was well matched with serological results. Moeover, age-specific differences in human postvaccination responses against the identical circulating strain was noted. In addition, children had the most cross-reactive response to both H3N2 and B-yamagata subtypes.
Conclusions: Our results suggest that prior exposure to H1 or B influenza virus may influence cross-reactivity of H3-specific postvaccination responses and consequently could influence the vaccine effectiveness. Our findings also support that there are age-specific differences in human postvaccination responses.

Keywords: cross-reactivity; seasonal influenza; vaccine.
 
Back
Top Bottom